TipRanks
Go Ultimate55% OFF

Marks Gilbert Lynn Insider Profile

11 Followers

Marks Gilbert Lynn, Director at AN2 Therapeutics, Inc., holds 84.16K shares in AN2 Therapeutics, Inc. (Ticker: ANTX).

Marks Gilbert Lynn's Trading History

ANTX
AN2 Therapeutics, Inc.
Oct 13, 2026DirectorUninformative Buy―$381.23K
ANTX
Insider Shares: 84.16K (0.22%)

Marks Gilbert Lynn has not reported any informative transactions for ANTX, therefore, performance cannot be measured.

DateTransactionAmountNo. of SharesPrice per ShareProfitLink to Report
Oct 13, 2026Uninformative Buy$0.002,283$0.00―
Jul 10, 2026Uninformative Buy$0.002,789$0.00―
Apr 10, 2026Uninformative Buy$0.003,775$0.00―
Jan 14, 2026Uninformative Buy$0.0011,560$0.00―
Oct 14, 2025Uninformative Buy$0.0010,367$0.00―

You May Also Like

Marks Gilbert Lynn insider profile FAQ

What stocks does Marks Gilbert Lynn hold?
Marks Gilbert Lynn holds: ANTX stocks.
What is Marks Gilbert Lynn's role in AN2 Therapeutics, Inc.?
Marks Gilbert Lynn's role in AN2 Therapeutics, Inc. is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.